A clinical trial of rebecsinib — an investigational drug that inhibits the ADAR1 gene involved in the growth of more than 20 cancers — is underway at UC San Diego.
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
